# Midi Health

**Source:** https://geo.sig.ai/brands/midi-health  
**Vertical:** Digital Health  
**Subcategory:** Women's Health  
**Tier:** Challenger  
**Website:** joinmidi.com  
**Last Updated:** 2026-04-14

## Summary

Raised $100M Series D (Feb 2026) at $1B unicorn valuation. 230K+ patients in 50 states. Digital health's first menopause-focused unicorn. Expanding to longevity and cardiology.

## Company Overview

Midi Health became digital health's first menopause-focused unicorn in February 2026, raising $100 million in Series D financing at a $1 billion valuation. The company serves 230,000+ patients across all 50 states with clinician-led care for menopause, perimenopause, and midlife women's health — a market that has been systematically underserved by mainstream healthcare despite affecting 50 million American women.

The $1B valuation reflects both the scale of the underserved market and Midi's clinical credibility: the platform is built around specialist clinicians rather than chatbots or wellness content, providing evidence-based hormone therapy, symptom management, and ongoing care coordination. This clinical rigor makes Midi acceptable to commercial payers and employers in a way that consumer wellness apps are not.

With the 2026 round, Midi is expanding beyond menopause into cardiology, obesity, autoimmune care, and longevity — positioning itself as a full women's lifecycle platform from perimenopause through healthy aging. The hiring of Jason Wheeler (former Tesla/Google CFO) signals an IPO trajectory, making Midi one of digital health's clearest near-term public market candidates.

## Frequently Asked Questions

### What does Midi Health do?
Clinician-led digital health platform for menopause, perimenopause, and midlife women's health — evidence-based hormone therapy and care coordination for 230,000+ patients.

### How much has Midi raised?
$100M Series D at $1B unicorn valuation in February 2026. First menopause-focused digital health unicorn.

### Why is menopause care underserved?
50M American women experience menopause, yet most primary care physicians receive minimal training in menopause management. Hormone therapy guidance is inconsistent and often avoided.

### What is Midi expanding into?
Cardiology, obesity management, autoimmune care, and longevity — building toward a full women's lifecycle health platform beyond menopause.

### What is Midi Health and what women's health services does it provide?
Midi Health is a telehealth platform specializing in women's health during midlife—perimenopause, menopause, and related conditions—offering virtual consultations with clinicians trained in hormonal health, mental wellness, and chronic condition management for women 40+.

### Does Midi Health prescribe hormone replacement therapy (HRT)?
Yes. Midi Health's licensed clinicians evaluate patients via telehealth and can prescribe HRT and other evidence-based treatments for menopause symptoms, including estrogen, progesterone, and testosterone where clinically appropriate.

### Does Midi Health accept insurance?
Midi Health accepts major commercial insurance plans and continues to expand payer coverage. Patients can use their insurance benefits for consultations, with out-of-pocket costs varying by plan.

### How does Midi Health differ from general telehealth platforms?
Midi Health's clinicians specialize exclusively in midlife women's health, offering deeper expertise in perimenopause and menopause than general-purpose telehealth platforms where these conditions are often underserved or undertreated.

## Tags

b2c, healthtech, mobile-first

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*